Recent Updates
Recently added Catalysts
RIGL Positive Sentiment Score: 70/100

Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference

Wednesday, January 7, 2026 1 min read
Key Takeaway: Rigel Pharmaceuticals will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. CEO Raul Rodriguez will provide a company overview during the event. The conference is a significant platform for showcasing Rigel's advancements in therapies for hematologic disorders and cancer.

Market Sentiment Analysis

POSITIVE FACTORS

  • Rigel Pharmaceuticals is actively participating in a major healthcare conference.
  • The presentation may enhance visibility and interest in Rigel's therapies.
  • The company is focused on improving treatments for hematologic disorders and cancer.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif.,Jan. 7, 2026/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and CEO, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 14, 2026 at 3:00 p.m. PT (6:00 p.m. ET).
To access the live webcast or archived recording, visit the Investor Relations section of the company's website atwww.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.

About RigelRigel Pharmaceuticals, Inc. (Nasdaq:RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visitwww.rigel.com.

Contact for Investors & Media:Investors:Rigel Pharmaceuticals, Inc.650.624.1232[email protected]

Media:David RosenArgot Partners646.461.6387[email protected]

SOURCE Rigel Pharmaceuticals, Inc.

Frequently Asked Questions

When will Rigel present at the J.P. Morgan Conference?

Rigel will present on January 14, 2026, at 3:00 p.m. PT.

Who will present for Rigel Pharmaceuticals?

Raul Rodriguez, the president and CEO, will present the company overview.

Where can I access the presentation?

The live webcast and archived recording will be available on Rigel's website.

What is Rigel Pharmaceuticals focused on?

Rigel focuses on developing therapies for hematologic disorders and cancer.

Tags: RIGL Viatris Investor Conferences Healthcare Rigel Pharmaceuticals J.P. Morgan Healthcare Conference Raul Rodriguez hematologic disorders cancer
Last updated: Jan 7, 2026